AIMC Topic: Pharmacovigilance

Clear Filters Showing 31 to 40 of 109 articles

What place for intelligent automation and artificial intelligence to preserve and strengthen vigilance expertise in the face of increasing declarations?

Therapie
In 2018, the "Ateliers de Giens" (Giens Workshops) devoted a workshop to artificial intelligence (AI) and led its experts to confirm the potential contribution and theoretical benefit of AI in clinical research, pharmacovigilance, and in improving th...

Supervised Machine Learning-Based Decision Support for Signal Validation Classification.

Drug safety
INTRODUCTION: Signal validation in pharmacovigilance is the process of evaluating data to decide whether evidence is sufficient to justify further assessment of a detected signal. During the signal validation process, safety experts in our organizati...

Artificial Intelligence-Based Pharmacovigilance in the Setting of Limited Resources.

Drug safety
With the rapid development of artificial intelligence (AI) technologies, and the large amount of pharmacovigilance-related data stored in an electronic manner, data-driven automatic methods need to be urgently applied to all aspects of pharmacovigila...

Applying Machine Learning in Distributed Data Networks for Pharmacoepidemiologic and Pharmacovigilance Studies: Opportunities, Challenges, and Considerations.

Drug safety
Increasing availability of electronic health databases capturing real-world experiences with medical products has garnered much interest in their use for pharmacoepidemiologic and pharmacovigilance studies. The traditional practice of having numerous...

Artificial Intelligence Based on Machine Learning in Pharmacovigilance: A Scoping Review.

Drug safety
INTRODUCTION: Artificial intelligence based on machine learning has made large advancements in many fields of science and medicine but its impact on pharmacovigilance is yet unclear.

Industry Perspective on Artificial Intelligence/Machine Learning in Pharmacovigilance.

Drug safety
TransCelerate reports on the results of 2019, 2020, and 2021 member company (MC) surveys on the use of intelligent automation in pharmacovigilance processes. MCs increased the number and extent of implementation of intelligent automation solutions th...

Artificial Intelligence in Pharmacovigilance: An Introduction to Terms, Concepts, Applications, and Limitations.

Drug safety
The tools of artificial intelligence (AI) have enormous potential to enhance activities in pharmacovigilance. Pharmacovigilance experts need not be AI experts, but they should know enough about AI to explore the possibilities of collaboration with th...

Artificial Intelligence and Machine Learning for Safe Medicines.

Drug safety
Authors' views on the role of artificial intelligence and machine learning in pharmacovigilance. (MP4  139807 kb).

A contextual multi-task neural approach to medication and adverse events identification from clinical text.

Journal of biomedical informatics
Effective wide-scale pharmacovigilance calls for accurate named entity recognition (NER) of medication entities such as drugs, dosages, reasons, and adverse drug events (ADE) from clinical text. The scarcity of adverse event annotations and underlyin...